Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010;14(6):1007.
doi: 10.1186/cc9330. Epub 2010 Dec 1.

What procalcitonin brings to management of sepsis in the ICU

Affiliations
Review

What procalcitonin brings to management of sepsis in the ICU

Michel Wolff et al. Crit Care. 2010.

Abstract

In inflammatory states, particularly in response to infectious stimuli, local procalcitonin (PCT) production rises, and because these tissues cannot further process PCT into calcitonin, serum levels increase. In the critical care setting, PCT should be considered a useful tool to help physicians in some specific, although frequent, situations. Serial measurements of PCT levels may indicate the effectiveness of medical decisions such as the appropriateness of antibiotic therapy, the detection of new infections, and the exclusion of a diagnosis of sepsis. PCT-guided algorithms may also help to decrease the duration of antimicrobial therapy. However, the role of PCT as a prognostic marker in critically ill patients is controversial. In a study by Karlsson and colleagues, PCT concentrations did not differ between hospital survivors and nonsurvivors, but the outcome was better in patients whose PCT concentrations decreased more than 50%. The study of PCT kinetics thus could offer an individual risk assessment in patients with severe sepsis.

PubMed Disclaimer

Comment in

Comment on

References

    1. Karlsson S, Heikkinen M, Pettilä V, Alila S, Väisänen S, Pulkki K, Kholo E, Ruokonen E. Predictive value of procalcitonin decrease in patients with severe sepsis: a prospective observational study. Crit Care. 2010;14:R205. doi: 10.1186/cc9327. - DOI - PMC - PubMed
    1. Krüger S, Ewig S, Giersdorf S, Hartmann O, Suttorp N, Welte T, the CAPNETZ study group. Cardiovascular and inflammatory biomarkers to predict short-and long-term survival in community-acquired pneumonia. Am J Respir Crit Care Med. 2010. in press . - PubMed
    1. Bouadma L, Luyt CE, Tubach F, Cracco C, Alvarez A, Schwebel C, Schortgen F, Lasocki S, Veber B, Dehoux M, Bernard M, Pasquet B, Régnier B, Brun-Buisson C, Chastre J, Wolff M. Prorata trial group. Use of procalcitonin to reduce patient's exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet. 2010;375:463–474. doi: 10.1016/S0140-6736(09)61879-1. - DOI - PubMed
    1. Ramirez P, Garcia MA, Ferrer M, Aznar J, Valencia M, Sahuquillo JM, Menedez Rasenjo MA, Torres A. Sequential measurements of procalcitonin levels in diagnosing ventilator-associated pneumonia. Eur Respir J. 2008;31:356–362. doi: 10.1183/09031936.00086707. - DOI - PubMed
    1. Jung B, Embriaco M, Roux F, Forel JM, Demory D, Allardet-Servin J, Jaber S, La Scola B, Papazian L. Microbiological data, but not procalcitonin improve the accuracy of the clinical pulmonary infection score. Intensive Care Med. 2010;36:790–798. doi: 10.1007/s00134-010-1833-5. - DOI - PubMed